These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3153217)

  • 1. The role of meta-iodo [131I]benzylguanidine (MIBG) in the diagnosis and follow-up of neuroblastoma.
    Miceli A; Nespoli L; Burgio GR; Aprile C; Carena M; Saponaro R
    Pediatr Hematol Oncol; 1986; 3(1):37-47. PubMed ID: 3153217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
    Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M
    Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
    Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
    Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma.
    Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
    Diagn Imaging Clin Med; 1985; 54(1):21-7. PubMed ID: 3918823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
    Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D
    Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.
    Mastrangelo R; Lasorella A; Troncone L; Rufini V; Iavarone A; Riccardi R
    J Nucl Biol Med (1991); 1991; 35(4):252-4. PubMed ID: 1823829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
    Sautter-Bihl ML; Bihl H; Heinze HG
    Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
    Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
    Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
    Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
    J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma].
    Hervás Benito I; Rivas Sánchez A; Bello Arques P; Cañete A; Fernández JM; Saura Quiles A; González Cabezas P; Ruiz Rodríguez JC; Castell V; Pérez Pastor JL; Monfort JA; Mateo Navarro A
    Rev Esp Med Nucl; 2001 Aug; 20(5):369-76. PubMed ID: 11470071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and therapy control of neuroblastoma using meta-iodo- benzylguanidine].
    Kimmig B; Brandeis WE; Adolph J
    Dtsch Med Wochenschr; 1985 Feb; 110(5):175-9. PubMed ID: 3967603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
    Schwarz KB; Driver I; Lewis IJ; Taylor RE
    Br J Radiol; 1997 Jan; 70():90-2. PubMed ID: 9059302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of the biological activity of residual or recurrent neuroblastoma tumors with 131I-metaiodobenzylguanidine (MIBG) scintigraphy].
    Murashima S; Takeda K; Okuda Y; Nakagawa T; Sakurai M
    Kaku Igaku; 1990 Dec; 27(12):1393-400. PubMed ID: 2290210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
    Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
    Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
    El-Maghraby T
    Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
    Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
    Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of I-131 metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma].
    Iwashita S; Nakajo M; Nakabeppu Y; Tanoue T; Yonekura R; Taguchi M; Shimabukuro K; Shinohara S; Sakata H
    Kaku Igaku; 1989 Sep; 26(9):1135-47. PubMed ID: 2810911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].
    Klingebiel T; Reuland P; Feine U; Niethammer D
    Nuklearmedizin; 1992 Dec; 31(6):209-12. PubMed ID: 1491958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.